2/6/2012

The FDA asked an advisory committee to assess Marqibo, Talon Therapeutics' drug candidate for Philadelphia chromosome-negative acute lymphoblastic leukemia, on March 21. Marqibo is a capsule form of approved cancer treatment vincristine.

Related Summaries